Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.5600
+0.0050 (0.90%)
May 8, 2026, 3:55 PM AEST
Nyrada Market Cap
Nyrada has a market cap or net worth of 137.17 million as of May 8, 2026. Its market cap has increased by 521.11% in one year.
Market Cap
137.17M
Enterprise Value
130.05M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.56
Market Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 137.17M, an increase of 433.64%. That is a compound annual growth rate of 30.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 137.17M | -49.65% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 231.97M |
| Actinogen Medical | 168.80M |
| Recce Pharmaceuticals | 146.04M |
| Dimerix | 123.08M |
| Alterity Therapeutics | 108.75M |
| Island Pharmaceuticals | 103.57M |
| Arovella Therapeutics | 90.66M |
| Paradigm Biopharmaceuticals | 89.33M |